Alira Health

Learn more about our 2024 Global Biosimilars Report, which offers an assessment of trends in the global biosimilar market, with an emphasis on market and competitive dynamics in the US and Europe: https://lnkd.in/gKVPZQZa The report highlights key players, their biosimilar-related licensing and M&A activities, and examines the legal and regulatory landscape influencing market growth. Connect with the authors to discuss more about the report: 🔵 Alexandra Wollersheim, Partner 🔵 Joris Pezzini, Executive Vice President, Biopharma 🔵 Christian Hughes, Senior Manager 🔵 Nicole Clarke, PhD, MSM, Analyst 🔵 Alina Greimel, Analyst

We are pleased to announce that we will present at PHUSE EU Connect 2024. Make sure you join our presentations: 🔵 Harmonizing FDA and PMDA Submission Requirements with Luca Semeraro 🔵 Data Integration on CDISC ADaM Level: Multi-purpose Structure of ADSL and BDS Datasets with Renate Scheiner-Sparna 🔵 Automate Your Metadata: Reading and Modifying Information from PDF Files Using Python with Renate Scheiner-Sparna Read more about our three presentations: https://lnkd.in/ewdHU9F6 Connect with our team ahead of the event: Renate Scheiner-Sparna, Luca Semeraro, and Anamaria Dinu

Do you want key insights into the challenges and opportunities facing the biologics and advanced therapies contract development and manufacturing organization market as it navigates macro-economic uncertainty? Download the 2024 Biologics and Advanced Therapies Contract Manufacturing Report: https://lnkd.in/gtRrqUAt Connect with the authors to learn more about the report: Filippo Pendin, Mololuwa Oluwajobi, and Carlo S..

Join us on Thursday for our webinar, The Lupus Journey: Addressing Unmet Patient Needs: https://lnkd.in/gTAGzifZ In this session, a rheumatologist specializing in lupus will give us an overview of the variety of patient journeys she sees on a daily basis. You'll hear one patient’s complex journey of diagnosis and treatment of lupus. Join to learn similarities and differences in the patient journey between subgroups of people with lupus and to obtain the insights into the lupus patient journey and value-added takeaways for your lupus asset.

This week we attended Recruiting Day Verona Vicenza at Università degli Studi di Verona where we met with students interested in joining our team. Thank you to everyone who connected, and we hope you are excited about a future career with us. If you weren't able to attend, learn more about working at Alira Health: https://lnkd.in/emrJhDiZ

It was great to see everyone at the Patient Engagement Congress by MassMEDIC. During her panels, Pepi Hurtado-Lopez discussed the value of patient collaborations and putting patients first. Mario Arpaia was also on site to connect in-person with other experts. We enjoyed being in the company of professionals who agree that properly executed patient engagement strategies can lead to improved service of patient needs, improved outcomes, and maximized market access. Thank you to MassMEDIC and Rachel Robinson for organizing!

We examined the viability of developing a CGT in a non-orphan indication and addressed key considerations when evaluating the business case for a successful CGT product in a mainstream market, including pricing and delivery ecosystem considerations. Click right to see some of our findings, and download the full white paper: https://lnkd.in/exyD4K2x Connect with the authors: Bradford Ship and William Haines

Thanks to all who came to our working group at the World Orphan Drug Congress Europe: “Enhancing Patient Involvement in HTAs: Practical Strategies for Stakeholder Collaboration.” The experts explored key issues surrounding patient involvement in HTAs, with a focus on how pharmaceutical companies can actively contribute to this critical activity. Meet us at our booth to chat with the moderator, Luca Trentin. Connect with the speakers to continue the conversation: 🔹 Julien Delaye – Patient Engagement Manager, HTA at Eurordis 🔹 Cristina Montané Montals – Patient Advocate, ACAF (Association of People Affected by Fibromyalgia and other Central Sensitization Syndromes of Catalonia), Board Member of the Patients’ Council in Catalunya (CCPC) 🔹 Iolanda Arbiol – Director, Fundació Dr. Torrent-Farnell

As your regulatory partner, we can help you navigate the complex medical device regulation environment for the successful certification of your medical device in the European market. Partner with us to benefit from: 🔵 an in house team of experts covering all types of medical devices, including in-vitro software devices and combination products, among others. 🔵tailored services adapted to the product characteristics, stage of regulatory compliance and MDR requirements. 🔵a holistic approach to your needs thanks to our integrated team, including biometrics, clinical, market access, strategic consulting, and patient engagement experts. Click right to hear from Ainoa Forteza, our Vice President of Regulatory Affairs. Contact us to get started on your journey: https://lnkd.in/eFtaPbc5

Meet us at the World Orphan Drug Congress Europe! Don’t miss the opportunity to learn how we can help develop and commercialize rare disease treatments with the intense focus on the unique needs of rare disease patients that is crucial to success. Meet with our delegates: Annabel de Maria Bosch, Chief Patient Officer, Luca Trentin, Senior Consultant, Patient Engagement, Nerea Blanque Catalina 🌍, Partner, Market Access and Pricing, Mathieu Rosé, Director, Global Real-World Solutions, Rafael Alencar, Partner, Market Access and Pricing, Tabatha Bourgois, Business Development Director, Regulatory Affairs Dr. Ahmad Bechara, Executive Vice President, Global Pharma.